Current stock page

Catalysts

COGT Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

COGTCogent Biosciences, Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

BearishEdge 7/10
$28.56−$0.58 (−1.99%)

Latest quote

  • Momentum
    45
  • Value
    —
  • Quality
    40
  • Risk resilience
    51
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 16, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 44/100

Momentum 45/100 and sentiment — before the next covered event.

Recent coverage
3 articles

Updated Nov 15, 2026 · Sentiment 19.45%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 45/100AIQ Edge 7/10 Above Peers
Beat rate
50%
4 of 8 reported periods
Average surprise
+1.1%
Across covered historical reports
Latest result
-4.7%
Nov 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 5, 2026—-$0.56-$0.59-4.7%$5.22M—
Aug 10, 2026—-$0.55-$0.52+6.3%$1K—
May 5, 2026—-$0.53-$0.53+0.0%$500—
Feb 17, 2026—-$0.51-$0.55-7.8%$1.68M—
Nov 7, 2025—-$0.54-$0.50+7.4%——
Aug 5, 2025—-$0.55-$0.53+3.6%——
May 6, 2025—-$0.56-$0.52+7.1%——
Feb 25, 2025—-$0.59-$0.61-3.4%——

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
11
Buy
1
Hold
12-month analyst target
—
— versus current price
Based on 12 analyst observations. Targets are estimates, not predictions.
No analyst target path in this snapshot.
Low target
—
—
Average target
—
—
High target
—
—

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 16, 2027

Next known earnings or reporting date.

EPS estimate-$0.61

Current analyst expectation for the upcoming report.

Revenue estimate$5.44M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score45

Where event reaction would show up first.

AIQ score44/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
12

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
0
Negative
0
insidermonkey.com · Oct 20, 2026

Cogent Biosciences (COGT) Nears Three FDA Decisions. What Is Its Pipeline Worth?

Three Regulatory Reviews, No Established Earnings Base Cogent Biosciences, Inc.

gurufocus.com · Sep 15, 2026

Cogent Biosciences (COGT) FDA NDA Acceptance Highlights High P/S Valuation Amid Mixed Insider and Guru Activity

On September 15, 2026, Cogent Biosciences Inc (NASDAQ: COGT) announced that the U.S. Food and Drug Administration (FDA) has accepted its new drug application (N

seekingalpha.com · Aug 27, 2026

Cogent Biosciences: 3 NDAs Create A Time-To-Market Moat (NASDAQ:COGT)

Cogent Biosciences is positioned to commercialize bezuclastinib across three indications, leveraging a single precision molecule for multi-market entry. Learn more about COGT stock here.

Open full news and sentiment

COGT Catalysts FAQ

What are the next catalysts for COGT stock?

COGT's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move COGT stock?

Upcoming events that could move COGT include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could COGT's next earnings report affect the stock?

COGT's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive COGT stock higher?

COGT could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt COGT stock?

COGT could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.